Open Access Green as soon as Postprint is submitted to ZB.
The hand eczema proteome: Imbalance of epidermal barrier proteins.
Br. J. Dermatol. 172, 994-1001 (2015)
BACKGROUND: Chronic hand eczema is a frequent skin disease with a high socio-economic impact. While some light has been shed on genetic factors predisposing for the disease, little is known on its actual pathogenesis. OBJECTIVES: We therefore set out to systematically and comprehensively analyze the differential protein expression in chronic hand eczema using modern mass spectrometry. METHODS: We performed LC-MS/MS analyses and label-free quantification to analyze the proteomic profile of palmar skin from 12 individuals, 6 hand eczema patients and 6 healthy volunteers. Immunohistochemistry of palmar skin from 7 different hand eczema patients and 7 different healthy volunteers was performed in a second step. RESULTS: With this method we were able to identify 185 candidate proteins whose abundance was significantly different in the hand eczema samples. Among them we found several barrier proteins: filaggrin, filaggrin2 and hornerin all were down-regulated in the hand eczema samples as were the desquamation-related enzymes kallikrein-related peptidase 5 and 7 as well as cystatin E/M. The antimicrobial peptides S100A7 and S100A8/A9 as well as the small proline-rich protein 2B and S100A11 were up-regulated in diseased skin. Immunohistochemistry confirmed these findings. CONCLUSIONS: Our results corroborate the assumption that skin barrier dysfunction plays an essential role in the pathogenesis of chronic hand eczema.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.275
1.961
32
34
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Barrier Proteins ; Chronic Hand Eczema ; Epidermal Barrier ; Proteome ; Proteomics; Quality-of-life; Allergic Contact-dermatitis; Atopic-dermatitis; S100a8/s100a9 Calprotectin; Cystatin-m/e; Routine Care; Label-free; Skin; Differentiation; Multicenter
Language
english
Publication Year
2015
Prepublished in Year
2014
HGF-reported in Year
2014
ISSN (print) / ISBN
0007-0963
e-ISSN
1365-2133
Quellenangaben
Volume: 172,
Issue: 4,
Pages: 994-1001
Publisher
Wiley
Publishing Place
Hoboken
Reviewing status
Peer reviewed
Institute(s)
CF Metabolomics & Proteomics (CF-MPC)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505700-001
PubMed ID
25244099
WOS ID
WOS:000351952100059
Scopus ID
84926170304
Erfassungsdatum
2014-09-24